Tricolorin A, a potent natural uncoupler and inhibitor of photosystem II acceptor side of spinach chloroplasts

Tricolorin A, (11 S )-11-hydroxyhexadecanoic acid 11- O - α - l - rhamnopyranosyl-(1↠3)- O - α - l -{2- O -(2 S -methylbutanoyl)-4- O -(2 S -methylbutanoyl)}-rhamnopyranosil-(1↠2)- O - β - d -glucopyranosil-(1↠2)- β -fucopyranoside-(1,3'-lactone), the major phytogrowth inhibitor isolated from Ipomoea tricolor Cav. (Convolvulaceae) was found to be a potent uncoupler (U₅₀=0.33 μ M ) of photophosphorylation in spinach chloroplasts. Tricolorin A inhibited H⁺-uptake and adenosine 5'-triphosphate (ATP) synthesis, and stimulated basal and phosphorylating electron flows. Using a combination of two well-known fluorescent ΔpH probes, 9-aminoacridine and 9-amino-6-chloro-2-methoxyacridine, the uncoupling behavior of tricolorin A was also demonstrated for submitochondrial particles. Polarographic data showed that high concentrations (20 μ M ) of tricolorin A inhibited photosystem II (PSII) electron flow at the level of plastoquinone B (Q_B). Chlorophyll (Chl) a fluorescence analysis showed that tricolorin A induced accumulation of Q_A⁻ and strongly decreased the electron transport capacity, suggesting that the target of this molecule was located at the Q_B level. The macrocyclic lactone-type structure of this allelopathic agent proved to be an important structural requirement for uncoupling activity since its hydrolysis caused loss of the inhibitory potential.     

A Stochastic Model of Gene Evolution with Time Dependent Pseudochaotic Mutations

We develop here a new class of stochastic models of gene evolution in which a random subset of the 64 possible trinucleotides mutates at each evolutionary time t according to some time dependent substitution probabilities. Therefore, at each time t, the numbers and the types of mutable trinucleotides are unknown. Thus, the mutation matrix changes at each time t. This pseudochaotic model developed generalizes the standard model in which all the trinucleotides mutate at each time t. It determines the occurrence probabilities at time t of trinucleotides which pseudochaotically mutate according to 3 time dependent substitution parameters associated with the 3 trinucleotide sites. The main result proves that under suitable assumptions, this pseudochaotic model converges to a uniform probability vector identical to that of the standard model. Furthermore, an application of this pseudochaotic model allows an evolutionary study of the 3 circular codes identified in both eukaryotic and prokaryotic genes. A circular code is a particular set of trinucleotides whose main property is the retrieval of the frames in genes locally, i.e., anywhere in genes and particularly without start codons, and automatically with a window of a few nucleotides. After a certain evolutionary time and with particular time dependent functions for the 3 substitution parameters, precisely an exponential decrease in the 1st and 2nd trinucleotide sites and an exponential increase in the 3rd one, this pseudochaotic model retrieves the main statistical properties of the 3 circular codes observed in genes. Furthermore, it leads to a circular code asymmetry stronger than the standard model (nonpseudochaotic) and, therefore, to a better correlation with the genes.     

Quantitative and qualitative adaptation of skeletal muscle mitochondria to increased physical activity

Endurance capacity rely on high muscle oxidative capacity but should also involve a tighter coupling between energy production and utilization within the myocyte. The present study examined the responses of muscle oxidative capacity and the regulation of oxidative phosphorylation by phosphate acceptors in locomotor muscles of voluntary running rats (n = 8), using saponin permeabilized fibers of the deep and superficial parts of plantaris muscle (dPLA and sPLA, respectively). Non-ADP stimulated respiration of skinned fibers increased by 33% (P < 0.05) and 100% (P < 0.001) in sPLA and dPLA, respectively. The maximal ADP-stimulated respiration was 57% (P < 0.001) and 32% (P < 0.01) higher in active rats than in sedentary rats (n = 8), in sPLA and dPLA, respectively. This finding was consistent with a 72% increase in the CS activity in plantaris muscle of exercising rats (P < 0.01). Voluntary running induced a 334% increase in the apparent Km for ADP in sPLA (P < 0.001), and a 61% increase in dPLA (P < 0.05), showing a lower affinity for cytosolic ADP of mitochondria present in both, predominantly glycolytic, and oxidative fibers. There was an increase in the creatine kinase efficacy in both sPLA and dPLA (131%, 75%, P < 0.001, respectively), consistent with an increase in the activity of the mitochondrial isoform of creatine kinase (106%, P < 0.01). It is concluded that, in addition to the well-known increased oxidative capacity, voluntary running is associated with changes in the regulation of oxidative phosphorylation by phosphate acceptors, in both glycolytic and oxidative fibers, in the direction of increased coupling between energy production and energy utilization.     

Colocalization of L-phenylalanine ammonia-lyase and cinnamate 4-hydroxylase for metabolic channeling in phenylpropanoid biosynthesis

Metabolic channeling has been proposed to occur at the entry point into plant phenylpropanoid biosynthesis. To determine whether isoforms of L-Phe ammonia-lyase (PAL), the first enzyme in the pathway, can associate with the next enzyme, the endomembrane-bound cinnamate 4-hydroxylase (C4H), to facilitate channeling, we generated transgenic tobacco (Nicotiana tabacum) plants independently expressing epitope-tagged versions of two PAL isoforms (PAL1 and PAL2) and C4H. Subcellular fractionation and protein gel blot analysis using epitope- and PAL isoform-specific antibodies indicated both microsomal and cytosolic locations of PAL1 but only cytosolic localization of PAL2. However, both PAL isoforms were microsomally localized in plants overexpressing C4H. These results, which suggest that C4H itself may organize the complex for membrane association of PAL, were confirmed using PAL-green fluorescent protein (GFP) fusions with localization by confocal microscopy. Coexpression of unlabeled PAL1 with PAL2-GFP resulted in a shift of fluorescence localization from endomembranes to cytosol in C4H overexpressing plants, whereas coexpression of unlabeled PAL2 with PAL1-GFP did not affect PAL1-GFP localization, indicating that PAL1 has a higher affinity for its membrane localization site than does PAL2. Dual-labeling immunofluorescence and fluorescence energy resonance transfer (FRET) studies confirmed colocalization of PAL and C4H. However, FRET analysis with acceptor photobleaching suggested that the colocalization was not tight.     

Modification of CETP function by changing its substrate preference: a new paradigm for CETP drug design

We previously determined that hamster cholesteryl ester transfer protein (CETP), unlike human CETP, promotes a novel one-way transfer of TG from VLDL to HDL, causing HDL to gain lipid. We hypothesize that this nonreciprocal lipid transfer activity arises from the usually high TG/cholesteryl ester (CE) substrate preference of hamster CETP. Consistent with this, we report here that ∼25% of the total lipid transfer promoted by the human Q199A CETP mutant, which prefers TG as substrate, is nonreciprocal transfer. Other human CETP mutants with TG/CE substrate preferences higher or lower than wild-type also possess nonreciprocal lipid transfer activity. Mutants with high TG/CE substrate preference promote the nonreciprocal lipid transfer of TG from VLDL to HDL, but mutants with low TG/CE substrate preference promote the nonreciprocal lipid transfer of CE, not TG, and this lipid flow is in the reverse direction (from HDL to VLDL). Anti-CETP TP2 antibody alters the TG/CE substrate preference of CETP and also changes the extent of nonreciprocal lipid transfer, showing the potential for externally acting agents to modify the transfer properties of CETP. Overall, these data show that the lipid transfer properties of CETP can be manipulated. Function-altering pharmaceuticals may offer a novel approach to modify CETP activity and achieve specific modifications in lipoprotein metabolism.